Bioburden control within continuous manufacturing

 

Bioburden control within continuous manufacturing is a key area of concern in the biotech industry. In this short video from Pall Biotech, Britta Manser outlines how existing technologies can help mitigate potential risks linked to bioburden control among new technologies.



Do you like the idea of producing 100 g of your mAb product every day? This is now possible using a continuous processing platform. Download a brochure to discover how.

Subscribe to our FREE newsletter

We will not sell or give your information to a third party. See our Privacy Policy